(Q43269144)

17 November 2017

title

Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats (English)

1 reference

17 November 2017

Saku Miyamoto

1

1 reference

17 November 2017

Akemi Matsumoto

series ordinal

2

1 reference

17 November 2017

Ikuo Mori

series ordinal

3

1 reference

17 November 2017

Akira Horinouchi

series ordinal

4

1 reference

17 November 2017

language of work or name

1 reference

1 October 2009

1 reference

Toxicology Mechanisms and Methods

17 November 2017

published in

1 reference

17 November 2017

volume

19

1 reference

17 November 2017

issue

8

1 reference

17 November 2017

page(s)

477-485

1 reference

Tetracycline-induced steatosis in primary canine hepatocyte cultures

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Drug-induced phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Cationic amphiphilic drug-induced phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Gene expression profiling in rat liver treated with compounds inducing phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Validation of an in vitro screen for phospholipidosis using a high-content biology platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Drug-induced Phospholipidosis -Pathological Aspects and Its Prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Drug-induced phospholipidosis: issues and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Assessment of drug-lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

Antidepressant-induced lipidosis with special reference to tricyclic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376510903322834

10.1080/15376510903322834

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference